Fluorine in PDB 5u45: Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14

Protein crystallography data

The structure of Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14, PDB code: 5u45 was solved by C.-C.Wu, T.J.Baiga, M.Downes, J.J.La Clair, A.R.Atkins, S.B.Richard, T.A.Stockley-Noel, M.E.Bowman, R.M.Evans, J.P.Noel, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 47.80 / 1.95
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 39.530, 95.260, 96.440, 90.00, 97.56, 90.00
R / Rfree (%) 19 / 24.1

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14 (pdb code 5u45). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14, PDB code: 5u45:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 5u45

Go back to Fluorine Binding Sites List in 5u45
Fluorine binding site 1 out of 2 in the Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F502

b:31.3
occ:1.00
F A:7SY502 0.0 31.3 1.0
C28 A:7SY502 1.3 37.4 1.0
C27 A:7SY502 2.4 32.0 1.0
C24 A:7SY502 2.4 32.5 1.0
HE2 A:PHE316 2.6 49.6 1.0
H25 A:7SY502 2.6 39.0 1.0
H28 A:7SY502 2.6 38.4 1.0
HG11 A:VAL312 2.7 47.2 1.0
HG22 A:VAL245 2.9 37.5 1.0
HG13 A:VAL245 3.0 29.0 1.0
HD21 A:LEU317 3.1 42.6 1.0
HG21 A:VAL312 3.3 39.3 1.0
HG13 A:VAL312 3.3 47.2 1.0
HD2 A:PHE316 3.4 47.2 1.0
CE2 A:PHE316 3.4 41.3 1.0
HG21 A:VAL245 3.4 37.5 1.0
HD23 A:LEU317 3.4 42.6 1.0
CG1 A:VAL312 3.5 39.4 1.0
HG11 A:VAL245 3.5 29.0 1.0
CG2 A:VAL245 3.6 31.3 1.0
CG1 A:VAL245 3.6 24.2 1.0
C26 A:7SY502 3.6 31.8 1.0
C21 A:7SY502 3.6 31.6 1.0
CD2 A:LEU317 3.7 35.5 1.0
CD2 A:PHE316 3.8 39.3 1.0
HG22 A:VAL312 3.8 39.3 1.0
CG2 A:VAL312 3.9 32.7 1.0
HD13 A:LEU219 4.0 51.8 1.0
HG21 A:ILE213 4.0 40.1 1.0
C25 A:7SY502 4.1 32.1 1.0
HG12 A:VAL312 4.2 47.2 1.0
HD22 A:LEU317 4.2 42.6 1.0
CB A:VAL245 4.2 27.6 1.0
CB A:VAL312 4.3 29.9 1.0
HG23 A:VAL245 4.4 37.5 1.0
HD22 A:LEU219 4.4 63.8 1.0
HG22 A:ILE213 4.4 40.1 1.0
HG12 A:VAL245 4.4 29.0 1.0
H27 A:7SY502 4.5 38.1 1.0
H20 A:7SY502 4.5 34.5 1.0
HA A:VAL245 4.5 24.7 1.0
CZ A:PHE316 4.6 36.8 1.0
HD11 A:LEU320 4.7 37.8 1.0
CG2 A:ILE213 4.7 33.4 1.0
HB A:VAL312 4.7 35.9 1.0
HZ A:PHE316 4.7 44.1 1.0
HG A:LEU317 4.8 40.6 1.0
HG23 A:VAL312 4.8 39.3 1.0
CG A:LEU317 4.9 33.8 1.0
CD1 A:LEU219 4.9 43.1 1.0
C19 A:7SY502 4.9 26.8 1.0
HB A:VAL245 5.0 33.1 1.0
CA A:VAL245 5.0 20.6 1.0
HD11 A:LEU219 5.0 51.8 1.0
HD13 A:ILE213 5.0 37.6 1.0

Fluorine binding site 2 out of 2 in 5u45

Go back to Fluorine Binding Sites List in 5u45
Fluorine binding site 2 out of 2 in the Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human Ppardelta Ligand-Binding Domain in Complexed with Specific Agonist 14 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F502

b:32.1
occ:1.00
F B:7SY502 0.0 32.1 1.0
C28 B:7SY502 1.3 24.2 1.0
C27 B:7SY502 2.4 16.6 1.0
C24 B:7SY502 2.4 20.0 1.0
HE2 B:PHE316 2.5 37.7 1.0
H28 B:7SY502 2.6 19.9 1.0
H25 B:7SY502 2.6 24.0 1.0
HG22 B:VAL245 2.6 28.3 1.0
HG13 B:VAL245 2.9 37.9 1.0
HG11 B:VAL312 2.9 29.3 1.0
HG21 B:VAL245 3.1 28.3 1.0
HD21 B:LEU317 3.1 27.7 1.0
CG2 B:VAL245 3.3 23.6 1.0
HG11 B:VAL245 3.3 37.9 1.0
CE2 B:PHE316 3.4 31.4 1.0
CG1 B:VAL245 3.5 31.6 1.0
HD23 B:LEU317 3.5 27.7 1.0
HG13 B:VAL312 3.5 29.3 1.0
HD2 B:PHE316 3.6 41.5 1.0
HG21 B:VAL312 3.6 28.8 1.0
C26 B:7SY502 3.6 24.3 1.0
C21 B:7SY502 3.6 19.0 1.0
CG1 B:VAL312 3.7 24.4 1.0
HD13 B:LEU219 3.7 46.1 1.0
CD2 B:LEU317 3.8 23.1 1.0
CD2 B:PHE316 3.9 34.6 1.0
CB B:VAL245 4.0 26.0 1.0
HG21 B:ILE213 4.1 35.5 1.0
HG23 B:VAL245 4.1 28.3 1.0
C25 B:7SY502 4.1 25.3 1.0
HG22 B:VAL312 4.1 28.8 1.0
CG2 B:VAL312 4.2 24.0 1.0
HD22 B:LEU317 4.3 27.7 1.0
HG12 B:VAL312 4.3 29.3 1.0
HG12 B:VAL245 4.4 37.9 1.0
HA B:VAL245 4.4 24.3 1.0
HD11 B:LEU320 4.4 33.9 1.0
H27 B:7SY502 4.5 29.2 1.0
CZ B:PHE316 4.5 36.9 1.0
HG22 B:ILE213 4.5 35.5 1.0
H20 B:7SY502 4.5 31.6 1.0
CD1 B:LEU219 4.6 38.4 1.0
CB B:VAL312 4.6 25.2 1.0
HD11 B:LEU219 4.6 46.1 1.0
HD22 B:LEU219 4.6 44.9 1.0
HZ B:PHE316 4.6 44.3 1.0
HB B:VAL245 4.7 31.2 1.0
CG2 B:ILE213 4.8 29.6 1.0
CA B:VAL245 4.8 20.3 1.0
HG B:LEU317 4.8 30.7 1.0
C19 B:7SY502 4.9 22.1 1.0
HB B:VAL312 4.9 30.3 1.0
CG B:LEU317 5.0 25.6 1.0

Reference:

C.C.Wu, T.J.Baiga, M.Downes, J.J.La Clair, A.R.Atkins, S.B.Richard, W.Fan, T.A.Stockley-Noel, M.E.Bowman, J.P.Noel, R.M.Evans. Structural Basis For Specific Ligation of the Peroxisome Proliferator-Activated Receptor Delta. Proc. Natl. Acad. Sci. V. 114 E2563 2017U.S.A..
ISSN: ESSN 1091-6490
PubMed: 28320959
DOI: 10.1073/PNAS.1621513114
Page generated: Sun Dec 13 12:39:00 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy